Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Astellas sales and marketing update

Astellas launched Astagraf XL tacrolimus in the U.S. to prevent organ rejection in

Read the full 136 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE